CN106589135A - Targeting antibacterial peptide and preparation method and application thereof - Google Patents

Targeting antibacterial peptide and preparation method and application thereof Download PDF

Info

Publication number
CN106589135A
CN106589135A CN201611052825.3A CN201611052825A CN106589135A CN 106589135 A CN106589135 A CN 106589135A CN 201611052825 A CN201611052825 A CN 201611052825A CN 106589135 A CN106589135 A CN 106589135A
Authority
CN
China
Prior art keywords
ccf10
peptide
targeting
antibacterial peptide
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201611052825.3A
Other languages
Chinese (zh)
Other versions
CN106589135B (en
Inventor
单安山
徐林
丑淑丽
王家俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northeast Agricultural University
Original Assignee
Northeast Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northeast Agricultural University filed Critical Northeast Agricultural University
Priority to CN201611052825.3A priority Critical patent/CN106589135B/en
Publication of CN106589135A publication Critical patent/CN106589135A/en
Application granted granted Critical
Publication of CN106589135B publication Critical patent/CN106589135B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention discloses a targeting antimicrobial peptide and a preparation method and application thereof. A sequence of the targeting antimicrobial peptide cCF10-C4 is shown in a sequence table SEQ ID No.1. The preparation method comprises the steps that enterococcus faecalis serves as a target bacterium to obtain the targeting antimicrobial peptide cCF10-C4 through design, a series of multi-structural-domain antimicrobial peptide molecules having selectivity to the enterococcus faecalis are established in a heterozygous mode. The design of a series of antimicrobial peptide molecules mainly includes two independent functional areas, namely a sterilization area and an identification area respectively. The targeting antimicrobial peptide has targeting selection capability to the target bacterium. The targeting antimicrobial peptide cCF10-C4 is conductive to reestablishment of microecological balance after treatment.

Description

A kind of targeting antibacterial peptide and its preparation method and application
Technical field
The invention belongs to biological technical field, and in particular to a kind of targeting antibacterial peptide and its preparation method and application.
Background technology
Antibacterial peptide is the small molecule polypeptide being present in organism natural immune defence system, participates in the immunity of body Defense function, is that body resists first barrier that pathogenic microorganism is attacked.Antibacterial peptide is generally by 12-50 amino acid residue group Into molecular weight is less than 10kDa, and its common feature is containing positively charged aminoacid and hydrophobic amino acid, with amphipathic And cationic, there is killing or inhibiting effect to various bacteria, funguses, virus, parasite even cancerous cell.
But antibacterial peptide is identical with conventional antibiotic mostly to be extensive pedigree antibiotic, not only microorganism resistance mutation is produced Great selection pressure.Importantly, extensive pedigree antibiotic kill pathogen while also kill it is beneficial just Often flora, serious destruction is caused to microecological balance, cause the antibiotic such as clinically common secondary infection it is related and Send out disease, result in the state of an illness further deteriorate, the serious negative consequences such as extended treatment cycle.Therefore, a class is especially needed at present " intelligent " targeting antibacterials selective to pathogen, can be while pathogenic bacterium be killed, to microecological environment Cause minimally to destroy, this is beneficial to rebuild microecological balance, and for body digital preservation is provided.
The content of the invention
Based on above weak point, it is an object of the invention to provide a kind of targeting antibacterial peptide cCF10-C4 and its preparation side Method and application, the antibacterial peptide has targeting selective power to object bacteria.
The purpose of the present invention is realized by following technology:A kind of targeting antibacterial peptide cCF10-C4, its sequence such as sequence table SEQ Shown in ID No.1.
The present invention also has following technical characteristic:
1st, a kind of preparation method of targeting antibacterial peptide cCF10-C4 is as follows:
(1) using broad spectrum antimicrobial peptide C6 as female peptide, from the pheromone that there is specific recognition to act on to enterococcus faecalis CCF10 connects the two functional areas using GGG as connector as identification region, and design has been obtained to be had to object bacteria Selective antibacterial peptide cCF10-C6;
(2) replace the K in the 16th, cCF10-C6 active center with negatively charged E to reduce net positive charge number, design is obtained There is the targeting antibacterial peptide cCF10-C4 of specificity to object bacteria;
(3) cCF10-C4 peptide resins are obtained by Peptide synthesizer using solid-state chemical reaction method method, by the peptide resin for obtaining After TFA cuttings, a polypeptide is obtained;
(4) after reversed-phase high-performance liquid chromatography purification and Mass Spectrometric Identification, that is, the preparation of polypeptide is completed.
2nd, a kind of targeting antibacterial peptide cCF10-C4 as described above, the application in targeting antibacterials are prepared.
The experimental technique of the antibacterial peptide prepared by this method is simple, and the antibacterial peptide to obtaining carries out antibacterial and hemolytic activity Detection, find cCF10-C4 can specific killing enterococcus faecalis, to staphylococcus aureuses, staphylococcus epidermidiss, escherichia coli, S. pullonum, Salmonella typhimurium do not have inhibitory action, show accurately targeting specific, and with very low Hemolytic activity.In sum, cCF10-C4 is a kind of targeting antibacterial peptide with higher using value, that is, prove the method pair In the accurate targeting antibacterial peptide effect is significant of design.
Description of the drawings
Fig. 1 is the hemolytic activity result figure of antibacterial peptide.
Specific embodiment
With reference to embodiment and accompanying drawing, the present invention is described in further detail, but embodiments of the present invention are not limited In this.
Embodiment 1
Two methods of the present embodiment combining information element labelling technique and optimization positive changes be optimal to object bacteria The effect of specificity, antibacterial peptide cCF10- is obtained using enterococcus faecalis (Enterococcus faecalis) as object bacteria design C4, is constructed a series of to the selective Multidomain antibacterial peptide molecule of enterococcus faecalis by way of heterozygosis.The series The MOLECULE DESIGN of antibacterial peptide mainly includes two independent functional areas, and respectively sterilize region and identification region.
The design of antibacterial peptide
Using broad spectrum antimicrobial peptide C6 as female peptide, from the pheromone cCF10 that there is specific recognition to act on to enterococcus faecalis As identification region, the two functional areas are connected using GGG as connector, design has obtained having selectivity to object bacteria Antibacterial peptide cCF10-C6, replace the K in the 16th, cCF10-C6 active center with negatively charged E on this basis reduce it is net just Charge number, so as to further improve specificity of the targeting antibacterial peptide to object bacteria, design obtains having specificity to object bacteria Targeting antibacterial peptide cCF10-C4.The aminoacid sequence of antibacterial peptide is as shown in table 1.
The aminoacid sequence of the antibacterial peptide of table 1
Embodiment 2
Solid-state chemical reaction method method composite signal element labelling antibacterial peptide
1st, the preparation of antibacterial peptide is carried out one by one from C-terminal to N-terminal, is completed by Peptide synthesizer.First by Fmoc-X (X It is first aminoacid of C-terminal of each antibacterial peptide) Wang resins are linked into, then slough and X-Wang trees are obtained after Fmoc groups Fat;Again by Fmoc-Y-Trt-OH (9- fluorenes methoxy carboxyl-trimethyl-Y, Y is second aminoacid of each antibacterial peptide C-terminal);According to This program is synthesized to N-terminal from C-terminal successively, until synthesis is finished, the resin of the side chain protected for obtaining sloughing Fmoc groups;
2nd, in peptide resin obtained above, cutting reagent is added, under 20 DEG C of lucifuges 2h is reacted, filtered;Precipitation TFA (three Fluoroethanoic acid) washing, washing liquid is mixed with above-mentioned filtrate, Rotary Evaporators concentration, the pre-cooling for adding 10 times or so volumes is anhydrous Ether, -20 DEG C of precipitation 3h, separates out white powder thing, and 10min is centrifuged with 2500g, collects precipitation, then washs heavy with absolute ether Form sediment, vacuum drying obtains polypeptide, wherein cutting reagent by TFA, water and TIS (tri isopropyl chlorosilane) according to mass ratio 95: 2.5:2.5 mix;
3rd, column equilibration 30min is carried out using 0.2mol/L sodium sulfate (phosphoric acid is adjusted to pH7.5), uses 90% acetonitrile solution Dissolving polypeptide, filters, the anti-phase normal pressure posts of C18, and (eluant is methanol and aqueous sodium persulfate solution according to volume ratio to adopt gradient elution For 30:70~70:30 mixing), flow velocity is 1mL/min, and detection ripple is 220nm, collects main peak, lyophilizing;Recycle anti-phase C18 posts It is further purified, eluent A is 0.1%TFA/ aqueous solutions;Eluent B is 0.1%TFA/ acetonitrile solutions, and wash-out concentration is 25% B~40%B, elution time is 12min, and flow velocity is 1mL/min, then ibid collects main peak, lyophilizing;
4th, the identification of antibacterial peptide:Antibacterial peptide obtained above is analyzed through electron spray mass spectrometry, the purity of antibacterial peptide is big In 95%.
Embodiment 3
The measure of antibacterial peptide activity
1st, the measure of antibacterial activity:Antibacterial peptide is configured as into certain storing liquid in case using.Using micro broth dilution Method determines the minimal inhibitory concentration of several antibacterial peptides.It is dilute using two times using 0.01% acetic acid (containing 0.2%BSA) as diluent Interpretation of the law configures successively the antibacterial peptide solution of graded series.Take the μ L of above-mentioned solution 100 to be placed in 96 porocyte culture plates, then distinguish Add isopyknic bacterium solution to be measured (~105Individual/mL) in each hole.It is respectively provided with positive control (not containing containing bacterium solution anti- Bacterium peptide) and negative control (both without bacterium solution or without peptide).37 DEG C of constant temperature culture 20h, have no that bottom hole portion has muddy existing with naked eyes The as minimal inhibitory concentration of elephant.As a result it is as shown in table 2.
The bacteriostatic activity of the antibacterial peptide of table 2
It can be seen from Table 2 that, pheromone cCF10 does not have bacteriostatic activity, and antibacterial peptide C6 has broad spectrum antibiotic activity, even Meeting cCF10 can improve bacteriostatic activity of the antibacterial peptide to enterococcus faecalis (E.faecalis), and to the antibacterial work of other non-target bacterium Property show substantially reduction;When positive changes are reduced to 4 (cCF10-C4), lose to the antibacterial of all non-targeted bacterial strains Ability, but the bacteriostatic activity to E.faecalis does not have significant change, shows accurately targeting specific.
2nd, the measure of hemolytic activity:The fresh blood 1mL of collection people, during 2mLPBS solution is dissolved into after anticoagulant heparin, 1000g is centrifuged 5min, collects erythrocyte;Washed with PBS 3 times, then it is resuspended with 10mL PBS;Take 50 μ L red cell suspensions and 50 μ L The antibacterial peptide solution mix homogeneously of the variable concentrations dissolved with PBS, the constant-temperature incubation 1h in 37 DEG C of incubators;Take out after l h, 4 DEG C, 1000g centrifugation 5min;Take out supernatant microplate reader light-metering absorption value at 570nm;Average per group, and compare point Analysis.Wherein 50 μ L erythrocyte add 50 μ LPBS as negative control;50 μ L erythrocyte add 50 μ L0.1%Tritonx-100 as sun Property control.Minimum hemolytic concentration is antibacterial peptide concentration when antibacterial peptide causes 10% hemolysis rate.As a result it is as shown in Figure 1.As figure can To find out, the antibacterial peptide hemolytic activity compared with female peptide after link information element cCF10 is slightly improved, but cCF10-C4 is in maximum survey The hemolysis rate for determining to cause under 256 μM of concentration is still below 15%, illustrates that the antibacterial peptide has relatively low cytotoxicity.
Result above shows, the targeting antibacterial peptide cCF10-C4 that present invention design is obtained can specific killing enterococcus faecalis, To escherichia coli, staphylococcuses etc. without effect.Simultaneously relatively low cytotoxicity is shown, with developing into the anti-enterococcus faecalis of targeting The potentiality of medicine.
The > Northeast Agricultural Universities of < 110
A kind of targeting antibacterial peptides of the > of < 120 and its preparation method and application
The > 1 of < 160
The > 1 of < 210
The > 24 of < 211
The > PRT of < 212
The > artificial sequences of < 213
The > 1 of < 400
Leu Val Thr Leu Val Phe Val Gly Gly Gly Trp Lys Trp Lys Trp Glu Asn Gly Lys Trp
1 5 10 15 20
Lys Trp Lys Trp-NH2
21 24

Claims (3)

1. a kind of targeting antibacterial peptide cCF10-C4, it is characterised in that its sequence is as shown in sequence table SEQ ID No.1.
2. a kind of preparation method of targeting antibacterial peptide cCF10-C4, it is characterised in that method is as follows:
(1) using broad spectrum antimicrobial peptide C6 as female peptide, made from the pheromone cCF10 that there is specific recognition to act on to enterococcus faecalis For identification region, the two functional areas are connected using GGG as connector, design has obtained selective to object bacteria Antibacterial peptide cCF10-C6;
(2) replace the K in the 16th, cCF10-C6 active center with negatively charged E to reduce net positive charge number, design is obtained to mesh Mark bacterium has the targeting antibacterial peptide cCF10-C4 of specificity;
(3) cCF10-C4 peptide resins are obtained by Peptide synthesizer using solid-state chemical reaction method method, the peptide resin for obtaining is passed through After TFA cuttings, a polypeptide is obtained, sequence is as shown in sequence table SEQ ID No.1;
(4) after reversed-phase high-performance liquid chromatography purification and Mass Spectrometric Identification, that is, the preparation of polypeptide is completed.
3. applications of a kind of targeting antibacterial peptide cCF10-C4 in targeting antibacterials are prepared according to claim 1.
CN201611052825.3A 2016-11-25 2016-11-25 A kind of targeting antibacterial peptide and its preparation method and application Active CN106589135B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611052825.3A CN106589135B (en) 2016-11-25 2016-11-25 A kind of targeting antibacterial peptide and its preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611052825.3A CN106589135B (en) 2016-11-25 2016-11-25 A kind of targeting antibacterial peptide and its preparation method and application

Publications (2)

Publication Number Publication Date
CN106589135A true CN106589135A (en) 2017-04-26
CN106589135B CN106589135B (en) 2018-08-28

Family

ID=58593326

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611052825.3A Active CN106589135B (en) 2016-11-25 2016-11-25 A kind of targeting antibacterial peptide and its preparation method and application

Country Status (1)

Country Link
CN (1) CN106589135B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109232717A (en) * 2018-08-31 2019-01-18 东北农业大学 One kind is for Gram-negative bacteria targeting antibacterial peptide and production method and application

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0301078B1 (en) * 1987-02-06 1995-05-10 Xoma Corporation Polypeptides with activity against gram-positive and gram-negative bacteria
WO1998040401A2 (en) * 1997-03-10 1998-09-17 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
WO2001061029A2 (en) * 2000-02-17 2001-08-23 Zetatronics Limited Identification method
CN1532282A (en) * 2003-03-19 2004-09-29 成都阳辉生物科技有限责任公司 Novel antienterococci polypeptide and its preparing method
CN1671737A (en) * 2002-05-24 2005-09-21 应用超微***股份有限公司 Export and modification of (poly)peptides in the lantibiotic way
CN102827255A (en) * 2012-08-09 2012-12-19 东北农业大学 Antibacterial peptide GW13 and its preparation method and use
CN104592360A (en) * 2015-01-07 2015-05-06 中山大学 Alkaline antibacterial peptide as well as targeting design and application thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0301078B1 (en) * 1987-02-06 1995-05-10 Xoma Corporation Polypeptides with activity against gram-positive and gram-negative bacteria
WO1998040401A2 (en) * 1997-03-10 1998-09-17 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
WO2001061029A2 (en) * 2000-02-17 2001-08-23 Zetatronics Limited Identification method
GB2363842A (en) * 2000-02-17 2002-01-09 Zetatronics Ltd Micro-organism identification
CN1671737A (en) * 2002-05-24 2005-09-21 应用超微***股份有限公司 Export and modification of (poly)peptides in the lantibiotic way
CN1532282A (en) * 2003-03-19 2004-09-29 成都阳辉生物科技有限责任公司 Novel antienterococci polypeptide and its preparing method
CN102827255A (en) * 2012-08-09 2012-12-19 东北农业大学 Antibacterial peptide GW13 and its preparation method and use
CN104592360A (en) * 2015-01-07 2015-05-06 中山大学 Alkaline antibacterial peptide as well as targeting design and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ROBERT E.W.HANCOCK ET AL: "Cationic peptides:a new source of antibiotics", 《TIBTECH FEBRUARY》 *
SHIN YONG PARK ET AL: "Extracellular Gelatinase of Enterococcus faecalis Destroys a Defens System in Insect Hemolymph and human Serum", 《INFECTION AND IMMUNITY》 *
单安山: "抗菌肽的功能、研发与应用", 《中国农业科学》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109232717A (en) * 2018-08-31 2019-01-18 东北农业大学 One kind is for Gram-negative bacteria targeting antibacterial peptide and production method and application
CN109232717B (en) * 2018-08-31 2021-08-20 东北农业大学 Gram-negative bacterium targeted antibacterial peptide, and preparation method and application thereof

Also Published As

Publication number Publication date
CN106589135B (en) 2018-08-28

Similar Documents

Publication Publication Date Title
CN108570103B (en) One kind is rich in tryptophan antibacterial peptide WK12 and its preparation method and application
CN103923189B (en) Derived peptide IR2 of one boar derived antimicrobial peptide and its preparation method and application
CN109232717B (en) Gram-negative bacterium targeted antibacterial peptide, and preparation method and application thereof
CN107266533B (en) A kind of α spirals antibacterial peptide RL and its preparation method and application
CN107746429A (en) A kind of end symmetrical antibacterial peptide PP and its preparation method and application
CN106749532A (en) Multiply β hair fasteners small peptide and preparation method and application with tolerance protein enzyme
CN111423501B (en) Antibacterial peptide derived from scorpion venom as well as preparation method and application thereof
CN106749531A (en) Tryptophan slide fastener β hair fastener antibacterial peptides and preparation method thereof and with application
CN109810178A (en) A kind of resistance to enzymolysis antibacterial peptide I9H12 and its preparation method and application
CN107056893B (en) A kind of antibacterial peptide RF3 of the anti-Candida albicans of resistance to amphotericin B and application
CN111533786A (en) Beta-hairpin antibacterial peptide with tryptophan and arginine cross-chain interaction and preparation method thereof
CN112661832A (en) High-stability antibacterial peptide and application thereof
CN104650208B (en) Derived peptide of one breeder derived antimicrobial peptide and its preparation method and application
CN102827255B (en) Antibacterial peptide GW13 and its preparation method and use
CN117924424B (en) Beta-hairpin antibacterial peptide based on D-type amino acid cross-chain interaction, and preparation method and application thereof
CN113549137B (en) Proline-rich antibacterial peptide Pyr-2 targeting gram-negative bacteria and preparation method and application thereof
CN112778401B (en) Caprylic acid acylation modified antibacterial peptide and application thereof
CN102391362B (en) Group of animal-derived cationic antibacterial peptides and its application
CN106366162B (en) A kind of efficiently α spiral antibacterial peptides GV and its preparation method and application
CN111533781B (en) Non-specific receptor binding type fungus targeted antibacterial peptide and preparation method and application thereof
CN110294809B (en) Targeting staphylococcus aureus antibacterial peptide S2 and preparation method and application thereof
CN106589135B (en) A kind of targeting antibacterial peptide and its preparation method and application
CN102382186B (en) Antibacterial peptide GLI23 derived from linear chicken beta-phylaxin4 (RL38) and preparation method thereof
CN109705195B (en) Escherichia coli targeted antibacterial peptide KI-QK and preparation method and application thereof
CN106432513B (en) A kind of efficiently hybridization antibacterial peptide LI and its preparation method and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant